Loading clinical trials...
Loading clinical trials...
Comparison Between Ultrasound Guided Subacromial and Systemic Injection of Steroid for Frozen Shoulder: a Double Blind Multicenter Pilot Study for Randomized Control Trial
The goal of this multicenter pilot study is to validate the effectiveness of extending the injection interval between betamethasone doses from one to two weeks for treating frozen shoulder (adhesive capsulitis) in adults aged 18 to 75. This study also aims to screen potential study centers and gather data to refine the sample size calculation for a larger, future trial. The main questions it aims to answer are: * Does extending the interval between injections maintain effectiveness in improving shoulder function and reducing pain for frozen shoulder? * Which centers in this pilot study are qualified for a larger, future trial? * What is the appropriate sample size for conducting a multicenter RCT study with the same research design at the selected centers? Participants will: * Receive 3 injections over 4 weeks and will be followed up for another 8 weeks * Complete shoulder function assessments * Perform home rehabilitation exercises
Age
18 - 75 years
Sex
ALL
Healthy Volunteers
No
Guangde County People's Hospital
Xuancheng, Anhui, China
Yangpu District Central Hospital of Shanghai
Shanghai, Shanghai Municipality, China
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
The First People's Hospital of Linping District, Hangzhou
Hangzhou, Zhejiang, China
Huzhou Central Hospital
Huzhou, Zhejiang, China
Pujiang People's Hospital
Jinhua, Zhejiang, China
First Affiliated Hospital of Ningbo University
Ningbo, Zhejiang, China
Xiangshan County Traditional Chinese Medicine Hospital Healthcare Group
Ningbo, Zhejiang, China
Shengzhou People's Hospital
Shanhu, Zhejiang, China
Start Date
October 15, 2024
Primary Completion Date
August 21, 2025
Completion Date
September 2, 2025
Last Updated
January 30, 2026
40
ACTUAL participants
Compound betamethasone Injection(Gluteal muscle injection)
DRUG
Compound betamethasone Injection(Subacromial Ultrasound Guided injection)
DRUG
Normal Saline as Placebo (ultrasound-guided subacromial injection)
OTHER
Normal Saline as Placebo (gluteal muscle inection)
OTHER
home exercise
BEHAVIORAL
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
NCT07368751
NCT02283996
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06725823